OncoHost Raises $8 Million in Series B Funding Round

April 10, 2024

AI tool helps doctors pick optimum cancer treatment for patients

March 29, 2024

Observational study demonstrates clinical validity and utility of OncoHost’s PROphet NSCLC test

March 22, 2024

Study in JCO® Precision Oncology Validates Clinical Efficacy of OncoHost’s PROphet® NSCLC Test

March 21, 2024

OncoHost Wins AI Excellence Award

March 21, 2024

Study Demonstrates Clinical Validity of OncoHost’s NSCLC Test

February 26, 2024

Predicting immunotherapy success via biomarkers